TWST — Twist Bioscience Corp

—
Nasdaq · Health Care · Biotechnology · CIK 1581280 ·
Last close
$112.00
Market Cap
$7.43B
52W High
$219.71
52W Low
$24.41
ADV30
2,655,785
Next earnings
2027-02-01

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 — — — — — — —
Jun 2026 118,376,000 62,454,000 -36,280,000 -35,051,000 672,437,000 117,436,000 226,698,000
Mar 2026 110,715,000 57,122,000 -38,658,000 -44,021,000 676,214,000 122,670,000 221,120,000
Dec 2025 103,698,000 53,972,000 -33,100,000 -30,507,000 638,085,000 148,591,000 181,990,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-53,072,000
Investing CF
$-45,240,000
Financing CF
$13,797,000
CapEx
$-40,151,000
Dividends Paid
—
Buybacks
$-18,000
EPS Diluted TTM
$-2.22
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-1,429,157,000
Inventory
$35,162,000
Receivables
$87,581,000
ST Investments
$49,403,000
EBIT TTM
$-137,972,000
Pretax Income TTM
$-135,853,000
Interest Exp TTM
$143,000
Analysts
12

Yahoo Snapshot (yfinance, live)

Total Revenue
$431,798,016
EBITDA
$-115,282,000
Free Cash Flow
$-64,822,500
Enterprise Value
$7,919,389,696
Total Cash
$166,839,008
Total Debt
$108,590,000
Shares Out
66,301,174
Trailing EPS
$-2.22
Book Value
$7.11
ROE
-29.6%
ROA
-13.1%
Div Yield
—

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Sep 2026 459,433,000 -132,250,000 -130,202,000 1,121,808,000 233,792,000 888,016,000 -41,431,000
Sep 2025 376,572,000 -136,259,000 -77,670,000 641,861,000 168,903,000 472,958,000 -47,628,000
Sep 2024 312,974,000 -175,901,000 -208,726,000 614,323,000 141,634,000 472,689,000 -64,094,000
Sep 2023 245,109,000 -206,903,000 -204,618,000 776,403,000 152,971,000 623,432,000 -142,474,000
Sep 2022 203,565,000 -249,021,000 -217,863,000 961,378,000 171,993,000 789,385,000 -124,385,000

TTM Snapshot

Revenues TTM
$431,798,000
NetIncome TTM
$-136,717,000
OpCashFlow TTM
—
Assets (Latest)
$672,437,000
Forward EPS
$-0.63

Max Pain — expiry 2026-12-18

max pain strike: $145.00 · spot: $116.35 · call oi: 3,257 · put oi: 2,636
Expected Move to 2026-12-18: ±$24.55 (21.10%) — implied range $91.80 – $140.90 · ATM straddle on $115.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
CGON CG Oncology, Inc. $7.00B $78.94 —
IMVT Immunovant, Inc. $6.87B $33.21 —
IBRX ImmunityBio, Inc. $6.66B $6.26 —
KOD Kodiak Sciences Inc. $6.33B $96.80 —
KRYS Krystal Biotech, Inc. $8.85B $298.55 —

News headlines (Yahoo Finance, 1h cache)

Twist Bioscience Corporation Q4 2026 Earnings Call Summary
2026-11-12 22:15 · Yahoo
This Biotech's Guidance Seemingly Beat Expectations — But A Twist Slammed The Stock
2026-11-12 21:16 · Yahoo
Twist Bioscience Q4 Earnings Call Highlights
2026-11-12 21:14 · Yahoo
Twist Bioscience: 3 Key Takeaways for Long-Term Investors
2026-11-12 21:09 · Yahoo
Twist Bioscience earnings analysis: questions answered and next catalysts
2026-11-12 20:59 · Yahoo
Twist Bioscience (TWST) Q4 2026 Earnings Call Transcript
2026-11-12 19:45 · Yahoo
Full-Year Revenue Guidance and Strong Quarter Drove Twist Bioscience Corporation (TWST) Higher in Q3
2026-11-12 15:07 · Yahoo
Twist Bioscience: Fiscal Q4 Earnings Snapshot
2026-11-12 13:40 · Yahoo
Twist Bioscience (TWST) Reports Q4 Loss, Beats Revenue Estimates
2026-11-12 13:35 · Yahoo
Twist Bioscience Announces Fiscal 2026 Fourth Quarter and Full Year Financial Results
2026-11-12 12:15 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.